Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo - 100 mg
DRUG
2 trials
Sponsors
Pfizer
Conditions
Alopecia Areata
Chronic Spontaneous Urticaria
Phase 2
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Recruiting
NCT07219615
Pfizer
Chronic Spontaneous Urticaria
Start: 2025-10-30
End: 2027-04-23
Target: 200
Updated: 2026-06-17
Phase 3
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Recruiting
NCT06873945
Pfizer
Alopecia Areata
Start: 2025-04-01
End: 2028-03-19
Target: 674
Updated: 2026-09-18
Related Papers
Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata.
2025-10-14